InvestorsHub Logo
Followers 5
Posts 715
Boards Moderated 0
Alias Born 11/16/2022

Re: tschussmann1 post# 415220

Saturday, 05/13/2023 2:52:40 PM

Saturday, May 13, 2023 2:52:40 PM

Post# of 463867
No -- AVXL/FDA has to ultimately pick ONE pathway to AA. Either, a surrogate marker or an INTERMEDIATE clinical endpoint. We have no intermediate endpoint to consider. So, only surrogate marker is in play here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News